Diabetes
Faster epigenetic aging tracks metabolic syndrome risk in CARDIA
Open access · cc by · source: Europe PMC
In CARDIA adults with blood methylation clocks, higher MetS severity scores associated with intrinsic epigenetic age acceleration, and year-20 IEAA predicted incident MetS by year 30 (OR 1.05 per unit).
Study at a glance
- Design
- Cohort — CARDIA whole-blood methylation clocks (IEAA/EEAA) related to MetS
- N
- N=957 · Year-20 methylation sample with acceptable quality (year 15 n=1042)
- Population
- CARDIA adults with whole-blood DNA methylation at examinations 15 and/or 20
- Outcome
- Associations of epigenetic age acceleration with MetS severity and incident MetS
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
MetS severity associated positively with IEAA at years 15 and 20 (both P=0.016) and with EEAA at year 20 (P=0.040). Each additional MetS component linked to about +0.29 years of IEAA. Year-20 IEAA associated with incident MetS at year 30 (OR 1.05, 95% CI 1.01–1.10).
Methodology
In the Coronary Artery Risk Development in Young Adults (CARDIA) study, authors profiled whole-blood DNA methylation (Illumina MethylationEPIC) at examination years 15 and 20, computed intrinsic and extrinsic epigenetic age acceleration (IEAA/EEAA), and related these clocks to MetS severity and later incident MetS.
Limitations
Association of methylation age with MetS is not proof that slowing epigenetic clocks prevents MetS. OR 1.05 per IEAA unit is modest and needs context of score scale. Blood clocks are surrogates, not organ-specific MetS mechanisms.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Gut microbiota composition associates with metabolites and MetS-related traits in men.
In middle-aged men, gut microbiota composition associated with plasma metabolites and metabolic-syndrome–related traits — a microbiome correlate of MetS biology, not a proof that changing stool taxa remits the syndrome.
Scope note — different aging/epigenetic readout — not microbiome metabolites
Limits the claim's scope: a different population, assay, or outcome.
Higher MetS severity tracks faster epigenetic aging; year-20 IEAA predicts later incident MetS.
In CARDIA, MetS severity associated with intrinsic epigenetic age acceleration, and year-20 IEAA predicted year-30 incident MetS (OR 1.05 per unit) — a longitudinal methylation-age link, not a completed anti-aging MetS trial.
Evidence for the claim as stated.
Common GWAS SNPs capture a large share of MetS-trait heritability.
SNP-based models in ARIC/FHS suggest common markers explain much previously missing heritability for MetS traits (hg² ≈ 39% of h² in the authors’ median framing), with genetic correlations tracking phenotypic ones.
Scope note — epigenetic aging vs common-SNP heritability — both “omic,” different questions
Limits the claim's scope: a different population, assay, or outcome.
Microbiome correlates, methylation-age risk, acute dietary transcript shifts, and SNP heritability all sit under MetS without sharing one assay or one intervention claim.
Evidence for the claim as stated.
A modest OR linking IEAA to incident MetS is a different clinical claim from an acute 98-gene olive-oil meal effect — both can be true without interchangeable advice.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Microbiome correlates, methylation-age risk, acute dietary transcript shifts, and SNP heritability all sit under MetS without sharing one assay or one intervention claim.
A modest OR linking IEAA to incident MetS is a different clinical claim from an acute 98-gene olive-oil meal effect — both can be true without interchangeable advice.
Related papers in this topic
Same topic cluster — not a recommendation engine.